Search

HEALIUS LTD

Fechado

SetorSaúde

1.02 0.99

Visão Geral

Variação de preço das ações

24h

Atual

Mín

1.02

Máximo

1.02

Indicadores-chave

By Trading Economics

Vendas

-14M

682M

Funcionários

3,699

EBITDA

-91M

85M

Recomendações

By TipRanks

Recomendações

Vender

Previsão para 12 meses

-6.08% downside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

113M

657M

Abertura anterior

0.03

Fecho anterior

1.02

HEALIUS LTD Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

13 de jan. de 2026, 19:05 UTC

Grandes Movimentos do Mercado

Travere Therapeutics Shares Fall After FDA Extends Filspari Review

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Nikkei May Rise on Japan Election Hopes -- Market Talk

13 de jan. de 2026, 23:41 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

13 de jan. de 2026, 23:33 UTC

Conversa de Mercado

Gold Edges Higher, Supported by Ongoing Geopolitical Tensions -- Market Talk

13 de jan. de 2026, 23:13 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Plans to Withdraw Listing Status of Deppon Logistics From Shanghai Stock Exchange

13 de jan. de 2026, 23:10 UTC

Aquisições, Fusões, Aquisições de Empresas

JD Logistics Makes Cash Offer to Buy Deppon Logistics Shares It Doesn't Already Own

13 de jan. de 2026, 23:03 UTC

Conversa de Mercado

Woodside's Sales Revenue Likely Fell 13% in 4Q -- Market Talk

13 de jan. de 2026, 21:50 UTC

Aquisições, Fusões, Aquisições de Empresas

Netflix Preparing to Make Warner Bid All-Cash -- WSJ

13 de jan. de 2026, 21:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Katz Will Continue to Lead Day-To-Day Ops of FTN

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Transaction Strengthens Distribution Footprint and Expands Free-To-Watch Portfolio >VSNT

13 de jan. de 2026, 21:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Versant Media: Jonathan Katz, FTN's Founder, Has Joined VERSANT, Reporting to David Pietrycha >VSNT

13 de jan. de 2026, 21:15 UTC

Aquisições, Fusões, Aquisições de Empresas

VERSANT Completes Acquisition Of Free TV Networks >VSNT

13 de jan. de 2026, 21:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Array Digital Infrastructure Declares Special Dividend of $10.25 >AD

13 de jan. de 2026, 20:39 UTC

Conversa de Mercado

Silver Settles at Another New High -- Market Talk

13 de jan. de 2026, 20:21 UTC

Conversa de Mercado

Oil Futures Extend Rally On Rising Iran Tensions -- Market Talk

13 de jan. de 2026, 20:17 UTC

Conversa de Mercado

U.S. Natural Gas Edges Up on Coming Weather -- Market Talk

13 de jan. de 2026, 19:08 UTC

Aquisições, Fusões, Aquisições de Empresas

Super Micro Computer Is an AI Winner. Sell the Stock Anyway, Goldman Sachs Says. -- Barrons.com

13 de jan. de 2026, 19:03 UTC

Ganhos

Double-Digit Earnings Growth Could Continue. It Still Might Not Satisfy Investors. -- Barrons.com

13 de jan. de 2026, 18:50 UTC

Ganhos

JPMorgan's Unusual Quarter Weighs on Shares. How Apple Plays a Role. -- Barrons.com

13 de jan. de 2026, 17:54 UTC

Conversa de Mercado

UnitedHealth Reaffirms 2025 Guidance After Senate Report -- Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Global Equities Roundup: Market Talk

13 de jan. de 2026, 17:50 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Netflix Will Be a Winner No Matter How Warner Saga Ends -- Market Talk

13 de jan. de 2026, 17:49 UTC

Conversa de Mercado

Analysts Call For Potential Record Ethanol Output -- Market Talk

13 de jan. de 2026, 17:38 UTC

Conversa de Mercado

Merck CEO Sees $5B Market for Cidara's Flu Antiviral -- Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Financial Services Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

13 de jan. de 2026, 17:20 UTC

Conversa de Mercado
Aquisições, Fusões, Aquisições de Empresas

Basic Materials Roundup: Market Talk

13 de jan. de 2026, 17:19 UTC

Conversa de Mercado

Credit Cards Present Opportunity, Potential Obstacle for JPMorgan -- Market Talk

13 de jan. de 2026, 17:15 UTC

Conversa de Mercado

Merck CEO Sees Eventual Growth After Keytruda Exclusivity Expires -- Market Talk

HEALIUS LTD Previsão

Preço-alvo

By TipRanks

-6.08% parte inferior

Previsão para 12 meses

Média 0.92 AUD  -6.08%

Máximo 1.048 AUD

Mínimo 0.808 AUD

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para HEALIUS LTD - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Vender

2 ratings

0

Comprar

1

Manter

1

Vender

Informação Financeira

$

Sobre HEALIUS LTD

Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services. The company provides services under the Laverty Pathology, Dorevitch Pathology, QML Pathology, Western Diagnostic Pathology, Genomic Diagnostic, Vetnostics, QML Pathology, TML Pathology, Abbott Pathology, IQ, Pathology, Kossard, Gastrolab, and Agilex Biolabs brands. It operates medical laboratories, medical centers, patient collection centers, and community imaging centers. The company was formerly known as Primary Health Care Limited and changed its name to Healius Limited in December 2018. Healius Limited was incorporated in 1994 and is based in Sydney, Australia.
help-icon Live chat